CERENION awarded a key patent on its C-Trend® technology in Japan
A few weeks after obtaining patents in Europe and the USA, Cerenion has now been granted a key patent on its technology in Japan.
"This latest patent represents a significant expansion of the protection for our IPR on a major future market", remarks Dr. Jukka Kortelainen, Chief Medical Officer and head of IPR management at Cerenion.
Cerenion has filed multiple intellectual property applications on its technology worldwide.
Cerenion Oy has received support from the European Regional Development Fund of the European Union.
Cerenion Oy Elektroniikkatie 3 90590 Oulu FINLAND
Cerenion Oy Kyllikinportti 2 00240 Helsinki FINLAND